Evidence map›Paper›PMID 39881969›Full record

ArticleNuclear medicine and molecular imaging2025

Yong-Jin Park, Joon Ho Choi, Hyunjong Lee, Seung Hwan Moon, Inki Lee, Joohee Lee, Jang Yoo, Joon Young Choi, Korean Society of Nuclear Medicine Medical Affairs Committee

Abstract read
In one paragraph

Article in Nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Sex- and Age-Related Differences in Physiological [Bioengineering (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yong-Jin Park *Department of Nuclear Medicine, Ajou University Medical Center, Ajou University School of Medicine, Suwon, Republic of Korea.
Joon Ho Choi *Department of Nuclear Medicine, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Hyunjong LeeDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351 Republic of Korea.ORCID 0000-0001-5680-1382
Seung Hwan MoonDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351 Republic of Korea.
Inki LeeDepartment of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
Joohee LeeDepartment of Nuclear Medicine, CHA Ilsan Medical Center, CHA University, Goyang, Republic of Korea.
Jang YooDepartment of Nuclear Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
Joon Young ChoiDepartment of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351 Republic of Korea.
Korean Society of Nuclear Medicine Medical Affairs Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This guideline outlines the use of 3,4-dihydroxy-6-

Indexed as

FDOPA PET/CTGuidelineOncology

Identifiers

PMID39881969
PMCPMC11772901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.